Systemic Blockade of ACVR2B Ligands Protects Myocardium from Acute Ischemia-Reperfusion Injury

1Research Unit of Biomedicine, Department of Pharmacology and Toxicology, University of Oulu, 90220 Oulu, Finland; 2Biocenter Oulu, University of Oulu, 90220 Oulu, Finland; 3Neuromuscular Research Center, Biology of Physical Activity, Faculty of Sport and Health Sciences, University of Jyväskylä, 40014 Jyväskylä, Finland; 4Department of Physiology, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland; 5Medical Research Center Oulu, Oulu University Hospital and University of Oulu, 90220 Oulu, Finland; 6Wihuri Research Institute and Translational Cancer Biology Program, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland; 7Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA; 8Department of Medicine, University of Helsinki, 00029 Helsinki, Finland; 9Department of Medicine, Helsinki University Hospital, 00029 Helsinki, Finland